Koyfin Home > Directory > Health Care > Retrophin Inc > EBITDA / Interest Expenses

Retrophin Inc EBITDA / Interest Expenses Chart (RTRX)

Retrophin Inc annual/quarterly EBITDA / Interest Expenses from 2012 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Retrophin Inc EBITDA / Interest Expenses for the quarter ending June 06, 2020 was $-3m a -12.20% increase of 0m year over year
  • Retrophin Inc EBITDA / Interest Expenses for the last 12 months ending June 06, 2020 was $-3m a -42.37% increase of 1m year over year
  • Retrophin Inc Annual EBITDA / Interest Expenses for 2019 was $-4m a -25.17% increase of 1m from 2018
  • Retrophin Inc Annual EBITDA / Interest Expenses for 2018 was $-5m a 54.03% decrease of -3m from 2017
  • Retrophin Inc Annual EBITDA / Interest Expenses for 2017 was $-2m a -58.53% increase of 1m from 2016
Other Ratios Metrics:
  • Retrophin Inc Total Debt / Capital for the quarter ending September 09, 2018 was $40m a 66.90% increase of 27m year over year
  • Retrophin Inc Other Liabilities for the quarter ending December 12, 2018 was $91m a -9.17% decrease of -8m year over year
  • Retrophin Inc Total Debt / Equity for the quarter ending September 09, 2018 was $67m a 77.19% increase of 52m year over year
View Chart On Koyfin

Quarterly RTRX EBITDA / Interest Expenses Data

06/2020$-3m
03/2020$-2m
12/2019$-3m
09/2019$-3m
06/2019$-6m
03/2019$-5m
12/2018$-2m
09/2018$-6m
06/2018$-14m
03/2018$-9m

Annual RTRX EBITDA / Interest Expenses Data

2019$-4m
2018$-5m
2017$-2m
2016$-4m
2015$-2m
2014$-10m
2013$-534m
2012$-284m